Stammdaten
RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Unternehmen & Branche
| Name | RetinalGenix Technologies Inc. |
|---|---|
| Ticker | RTGN |
| CIK | 0001836295 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 60,0 Mio. USD |
| Beta | -3,72 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -2,428,595 | -0.13 | 21,041 | -2,302,611 | |
| 2025-09-30 | 10-Q | -568,791 | -0.03 | 7,001 | -2,172,730 | |
| 2025-06-30 | 10-Q | -649,418 | -0.03 | 8,388 | -1,981,165 | |
| 2025-03-31 | 10-Q | -587,259 | -0.03 | 11,931 | -1,667,936 | |
| 2024-12-31 | 10-K | -4,320,827 | -0.24 | 14,946 | -1,462,610 | |
| 2024-09-30 | 10-Q | -644,291 | -0.04 | 88,854 | -1,854,314 | |
| 2024-06-30 | 10-Q | -663,633 | -0.04 | 87,019 | -1,811,323 | |
| 2024-03-31 | 10-Q | -2,145,876 | -0.12 | 50,517 | -1,518,699 | |
| 2023-12-31 | 10-Q | -2,090,889 | 156 | -1,405,657 | ||
| 2023-12-31 | 10-K | -2,090,889 | -0.12 | 156 | -1,405,657 | |
| 2023-09-30 | 10-Q | -686,467 | -0.04 | 225 | -1,082,529 | |
| 2023-06-30 | 10-Q | -352,143 | -0.02 | 2,119 | -1,774,831 | |
| 2023-03-31 | 10-Q | -510,643 | -0.03 | 7,701 | -1,501,197 | |
| 2022-12-31 | 10-Q | -3,913,990 | 294 | -1,069,063 | ||
| 2022-12-31 | 10-K | -3,913,990 | -0.25 | 294 | -1,069,063 | |
| 2022-09-30 | 10-Q | -2,504,491 | -0.15 | 3,914 | -1,058,977 | |
| 2022-06-30 | 10-Q | -359,335 | -0.02 | 27 | -675,175 | |
| 2022-03-31 | 10-Q | -375,199 | -724,323 | |||
| 2021-12-31 | 10-K | -2,179,294 | 4,947 | -464,675 | ||
| 2021-09-30 | 10-Q | -551,023 | 36,578 | -412,708 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.